Study Stopped
the number of patients recruited at present is sufficient for analysis.
Feasibility Study of Balloon Kyphoplasty in Traumatic Vertebral Fractures Needing Surgical Fixation
TRAUMAA3B1C1
Prospective Cohort Study on the Feasibility and Reliability of 'Open' Balloon Kyphoplasty in Types A3.2, A3.3, B1 and C1 MAGERL Classification Vertebral Fractures(STIC 4)
1 other identifier
interventional
17
1 country
1
Brief Summary
Some unstable traumatic vertebral fractures (types A3.2, A3.3, B1 et C1 according to MAGERL classification) may undergo unpredictable secondary displacement. Such fractures require a two session surgery with a first operation carried out immediately to achieve posterior fixation and a second surgery which is performed some days later to stabilize the anterior spine and restore stress resistance. Goal of the present study is to show that percutaneous Balloon Kyphoplasty is able to restore anterior spine strength and replace second session surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Dec 2007
Typical duration for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2007
CompletedFirst Submitted
Initial submission to the registry
September 8, 2008
CompletedFirst Posted
Study publicly available on registry
September 9, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedJanuary 4, 2017
December 1, 2014
3.2 years
September 8, 2008
January 3, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Loss of less than 10 degrees in spine kyphosis angle at one year follow-up after surgery compared to postoperative measurements
1 year
Secondary Outcomes (10)
Pain evaluation using a visual analogic scale
J-20 to J-7 - J6 - J45 - J90 - J180 - J360
EIFEL questionnaire for back pain evaluation
J-20 to J-7 - J6 - J45 - J90 - J180 - J360
Quality of life evaluation (SF 12).
J-20 to J-7 - J6 - J45 - J90 - J180 - J360
Analgesics intake according to the WHO classification (Classes 1, 2 and 3).
J-20 to J-7 - J6 - J45 - J90 - J180 - J360
Regional spine Kyphosis angle and global thoracic and lumbar Kyphosis angle.
J-20 to J-7 - J6 - J45 - J90 - J180 - J360
- +5 more secondary outcomes
Study Arms (1)
1
OTHERBalloon kyphoplasty
Interventions
During the same surgery or some days later on, percutaneous Balloon kyphoplasty of the fractured vertebral body (ies) using polymethylmetacrylate cement injection through a posterior transpedicular approach will be carried out in replacement of anterior spine surgery to restore vertebral body strength
Eligibility Criteria
You may qualify if:
- Preliminary clinical examination (the anaesthesist must have provided his approval for the surgical procedure)
- Patient must have signed the consent form
- Male or female patient aged 18 or over
- One or two traumatic vertebral fractures located between T11 and L5 and type A3.2, A3.3, B1 or C1 in the MAGERL classification, and with a regional kyphotic angle \> 15° and treated by osteosynthesis through a posterior surgical approach with or without spinal decompression
- Fracture with or without neurological difficulties
- Non tumoral origin: Confirmed by biopsy at the same time of the Balloon Kyphoplasty procedure.
You may not qualify if:
- Non- traumatic, malignant or osteoporotic vertebral fractures
- History of surgical or percutaneous spine treatment except simple discectomy at a single or multiple vertebral levels with no residual pain.
- Known allergy to a contrast media or to one of the cement components used for kyphoplasty.
- More than two recent vertebral fractures
- Current infection
- Impossibility to perform the percutaneous approach of the vertebra to treat.
- Reduction by more than 50% of the anteroposterior width of the bony spinal canal due to the vertebral fracture to treat.
- Vertebral fracture with loss of 90%or more of the vertebral body height
- Patient presenting a non correctable spontaneous or therapeutic coagulation disorder.
- Evolutive cardiac disease nonreactive to medical treatment
- Non compliant patient: Impossibility to participate to the study and to be followed up for 1 year.
- Pregnant or breast feeding women
- Patient not affiliated to social security
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de Radiologie, Hôpital Lariboisière
Paris, 75010, France
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jean-Denis LAREDO, M.D.,PR.
AP/HP Assistance Publique-Hôpitaux de Paris
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 8, 2008
First Posted
September 9, 2008
Study Start
December 1, 2007
Primary Completion
March 1, 2011
Study Completion
March 1, 2011
Last Updated
January 4, 2017
Record last verified: 2014-12